IP analytics firm Clarivate beats Q3 estimates; raises FY sales view, keeps profit view

Reuters
10/29
IP analytics firm Clarivate beats Q3 estimates; raises FY sales view, keeps profit view

Overview

  • Clarivate Q3 2025 revenue and adjusted EPS beat analyst expectations

  • Company repurchased 11.7 mln shares and repaid $100 mln of debt in Q3

  • Adjusted net income and EBITDA exceeded analyst estimates

Outlook

  • Clarivate raises full-year 2025 revenue outlook to $2.42 bln-$2.45 bln

  • Company maintains 2025 adjusted EBITDA guidance at $940 mln-$1.00 bln

  • Clarivate keeps 2025 adjusted diluted EPS forecast at $0.60-$0.70

Result Drivers

  • SUBSCRIPTION GROWTH - Organic subscription revenues increased 1.2%, driven by new sales and price increases

  • REVENUE MIX IMPROVEMENT - Co reports 800 bps improvement in recurring revenue mix to 88%

  • VALUE CREATION PLAN - Co attributes improved financial performance to its Value Creation Plan, focusing on product and AI development

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$623.10 mln

$570 mln (8 Analysts)

Q3 Adjusted EPS

Beat

$0.18

$0.16 (10 Analysts)

Q3 Adjusted Net Income

Beat

$119.30 mln

$107.90 mln (5 Analysts)

Q3 Net Income

-$28.30 mln

Q3 Adjusted EBITDA

Beat

$252.40 mln

$239.60 mln (6 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the professional information services peer group is "buy."

  • Wall Street's median 12-month price target for Clarivate PLC is $4.90, about 25.7% above its October 28 closing price of $3.64

  • The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release: ID:nPrerKKTda

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10